← Leaderboards
Jianming Xu
Baylor College Of Medicine
$13,357,961
Attributed
$13,582,211
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$13,582,211 · 10
By mechanism
R01$9,029,452 · 4
P01$3,696,598 · 4
R21$856,161 · 2
Top collaborators
- Walid D. Fakhouri1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- David M Lonard$1,751,132
Others in their field
Top investigators on “Gene Targeting”
- David Heimbrook · Leidos Biomedical Research, Inc.$205,122,388
- Richard A Gibbs · Baylor College Of Medicine$161,086,449
- Barton F Haynes · Duke University$98,448,044
- Andrzej Joachimiak Joachimiak · University Of Chicago$94,692,413
- Eric Martin McDade · Washington University$94,632,845
- Stephen S. Rich · University Of Alabama At Birmingham$84,483,911
Research focus
Gene TargetingGenesMouse ModelNuclear ReceptorsMolecular TargetTranscription FactorMolecularKnock-OutResearch PersonnelOverexpressionProgramsPlayMediatingAffectCellsTumorPathway InteractionsFundingNeoplasm MetastasisTransgenesGeneticAnimalsMemberGrowth
Grant awards (54)
The function of TWIST1 acetylation in cell fate and tissue development$448,500
R21 · FY2023 · DE
The primary role of low NCOA6 expression in the prostate cancer disparity among African American men$183,261
R21 · FY2023 · CA · contact PI
Core B (Animal Component)$237,750
P01 · FY2022 · DK · contact PI
The primary role of low NCOA6 expression in the prostate cancer disparity among African American men$224,400
R21 · FY2022 · CA · contact PI
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer$287,519
R01 · FY2021 · CA · contact PI
Core B (Animal Component)$237,750
P01 · FY2021 · DK · contact PI
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer$374,023
R01 · FY2020 · CA · contact PI
Core B (Animal Component)$237,750
P01 · FY2020 · DK · contact PI
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer$362,803
R01 · FY2019 · CA · contact PI
Core B (Animal Component)$237,750
P01 · FY2019 · DK · contact PI
Core B (Animal Component)$237,750
P01 · FY2018 · DK · contact PI
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer$86,504
R01 · FY2018 · CA · contact PI
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer$374,023
R01 · FY2017 · CA · contact PI
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer$374,023
R01 · FY2016 · CA · contact PI
Animal Core$278,353
P01 · FY2016 · DK · contact PI
The Role of SRC-1 in Breast Cancer$269,732
R01 · FY2016 · CA · contact PI
Animal Core$278,353
P01 · FY2015 · DK · contact PI
The Role of SRC-1 in Breast Cancer$269,732
R01 · FY2015 · CA · contact PI
Animal Core$278,353
P01 · FY2014 · DK · contact PI
The Role of SRC-1 in Breast Cancer$261,640
R01 · FY2014 · CA · contact PI
Roles of SRC-3 in Development and Disease$293,418
R01 · FY2013 · DK · contact PI
Animal Core$267,690
P01 · FY2013 · DK · contact PI
The Role of SRC-1 in Breast Cancer$253,549
R01 · FY2013 · CA · contact PI
Roles of SRC-3 in Development and Disease$52,340
R01 · FY2013 · DK · contact PI
Roles of SRC-3 in Development and Disease$307,041
R01 · FY2012 · DK · contact PI
Animal Core$278,353
P01 · FY2012 · DK · contact PI
The Role of SRC-1 in Breast Cancer$269,732
R01 · FY2012 · CA · contact PI
Roles of SRC-3 in Development and Disease$310,051
R01 · FY2011 · DK · contact PI
Roles of SRC-3 in Development and Disease$356,771
R01 · FY2010 · DK · contact PI
The Role of SRC-1 in Breast Cancer$258,529
R01 · FY2010 · CA · contact PI
CORE--ANIMAL$230,732
P01 · FY2010 · DK · contact PI
Roles of SRC-3 in Development and Disease$360,375
R01 · FY2009 · DK · contact PI
The Role of SRC-1 in Breast Cancer$286,225
R01 · FY2009 · CA · contact PI
Role of AIB3 in Mammary Gland and Breast Cancer$280,899
R01 · FY2009 · CA · contact PI
The Role of SRC-1 in Breast Cancer$258,529
R01 · FY2009 · CA · contact PI
CORE--ANIMAL$233,063
P01 · FY2009 · DK · contact PI
Role of AIB3 in Mammary Gland and Breast Cancer$280,899
R01 · FY2008 · CA · contact PI
The Role of SRC-1 in Breast Cancer$258,529
R01 · FY2008 · CA · contact PI
CORE--ANIMAL$233,063
P01 · FY2008 · DK · contact PI
Role of AIB3 in Mammary Gland and Breast Cancer$280,899
R01 · FY2007 · CA · contact PI
The Role of SRC-1 in Breast Cancer$258,529
R01 · FY2007 · CA · contact PI
CORE--ANIMAL$254,888
P01 · FY2007 · DK · contact PI
Role of AIB3 in Mammary Gland and Breast Cancer$289,288
R01 · FY2006 · CA · contact PI
The Role of SRC-1 in Breast Cancer$266,250
R01 · FY2006 · CA · contact PI
CORE--ANIMAL$175,000
P01 · FY2006 · DK · contact PI
Role of AIB3 in Mammary Gland and Breast Cancer$296,250
R01 · FY2005 · CA
ROLES FOR SRC-3 IN DEVELOPMENT AND DISEASE$224,250
R01 · FY2004 · DK
ROLES FOR SRC-3 IN DEVELOPMENT AND DISEASE$224,250
R01 · FY2003 · DK
ROLES FOR SRC-3 IN DEVELOPMENT AND DISEASE$224,250
R01 · FY2002 · DK
CORE--ANIMAL$0
P01 · FY2002 · DK
ROLES FOR SRC-3 IN DEVELOPMENT AND DISEASE$224,250
R01 · FY2001 · DK
ROLES FOR SRC-3 IN DEVELOPMENT AND DISEASE$30,100
R01 · FY2001 · DK
CORE--ANIMAL$0
P01 · FY2001 · DK
ROLES FOR SRC-3 IN DEVELOPMENT AND DISEASE$224,250
R01 · FY2000 · DK